RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All Pharmacological Articles

Forest Tennant, MD, DrPH, advice for those thinking of co-prescribing benzos and opioids—leave it to the pain experts.
Call the forgotten opioid, physicians are rediscovering levorphanol as a safe and effective pain medication.
Dr. John Claude Krusz describes his protocol for the use of subanesthetic dosages of IV agents—ketamine, lidocaine, propofol—in an outpatient headache clinic.
Learn how emergency room physicians, dentists, rheumatologists, and orthopedic surgeons are dealing with new regulations and guidelines for pain management.
There are no perfect medications. This applies to both nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids. A high level of mortality is associated with both NSAIDs and opioids.
EpiPen’s astronomical price increase from $100 in 2007 to $600 today has caused quite a furor among parents and advocacy groups.
We wish to address 3 underappreciated, but salient points regarding tapentadol therapy using a case-based approach: First, the rarity of a true opioid allergy; second, the chemical similarity of phenylpropylamine opioids (tramadol, tapentadol); and, third, the unique pharmacodynamic attributes of tapentadol in the treatment of complex regional pain syndrom
Canadian researchers discuss 6 common concerns of patients and physicians regarding cannabis use for pain management.
Barth Wilsey, MD, shares his unique perspective and knowledge on the benefits and risks of therapeutic cannabis (medical marijuana).
10 Medication Myths. Learn more about what is and is not true about medical management of chronic pain.
Learn more about the correct dosing of different strains of medicinal cannabis used in Canada for the treatment of various pain conditions.
Genetic testing for metabolic abnormalities are critical tools for identifying patients who may require high-dose opioids.
Dr. Jennifer Schneider describes her experience with prescribing extended-release OxyContin to chronic pain patients.
A closer look at the debate between the Los Angeles Time reporters and Purdue Pharma regarding OxyContin's 12-hour dosing schedule.
SHOW MAIN MENU
SHOW SUB MENU